Pacific Biosciences
PACB
#7750
Rank
โ‚น40.78 B
Marketcap
โ‚น131.32
Share price
-2.86%
Change (1 day)
-1.37%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2026 (TTM): โ‚น14.30 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น15.45 Billion. In 2025 the company made a revenue of โ‚น14.36 Billion an increase over the revenue in the year 2024 that were of โ‚น13.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น14.30 B-0.39%
2025 โ‚น14.36 B8.71%
2024 โ‚น13.21 B-20.85%
2023 โ‚น16.69 B57.23%
2022 โ‚น10.61 B9.29%
2021 โ‚น9.71 B68.36%
2020 โ‚น5.76 B-10.98%
2019 โ‚น6.48 B17.89%
2018 โ‚น5.49 B-7.88%
2017 โ‚น5.96 B-3.19%
2016 โ‚น6.16 B-0.02%
2015 โ‚น6.16 B60.55%
2014 โ‚น3.84 B120.59%
2013 โ‚น1.74 B22.37%
2012 โ‚น1.42 B-20.58%
2011 โ‚น1.79 B2288.09%
2010 โ‚น75.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น4.364 T 28,142.20%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น4.889 T 31,542.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น424.18 B 2,645.11%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น324.19 B 1,998.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚น15.68 B 1.53%๐Ÿ‡บ๐Ÿ‡ธ USA